Eventide Asset Management - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$2,500,000
-39.9%
537,6000.0%0.16%
-35.8%
Q3 2016$4,161,000
+27.7%
537,6000.0%0.25%
+27.6%
Q2 2016$3,258,000
-28.9%
537,6000.0%0.20%
-22.3%
Q1 2016$4,580,000
-28.6%
537,6000.0%0.26%
-20.2%
Q4 2015$6,414,000
+69.3%
537,600
+43.1%
0.32%
+45.9%
Q3 2015$3,788,000
-15.8%
375,800
+38.6%
0.22%
-9.5%
Q2 2015$4,498,000
+58.8%
271,100
+48.1%
0.24%
+14.1%
Q1 2015$2,833,000
+15.4%
183,000
+18.1%
0.21%
-20.5%
Q4 2014$2,455,000
+48.4%
155,0000.0%0.27%
+16.0%
Q3 2014$1,654,000
+30.4%
155,000
+14.8%
0.23%
+34.3%
Q2 2014$1,268,000135,0000.17%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,434,783$60,326,0005.25%
RA Capital Management 9,880,323$109,672,0003.33%
BRIDGER MANAGEMENT, LLC 1,907,492$21,173,0001.53%
Eversept Partners, LP 776,323$8,617,1851.52%
Opaleye Management Inc. 579,651$6,434,0001.26%
Sofinnova Investments, Inc. 811,292$9,006,0000.65%
Ikarian Capital, LLC 316,200$3,510,0000.57%
ARMISTICE CAPITAL, LLC 800,000$8,880,0000.51%
683 Capital Management, LLC 398,271$4,421,0000.51%
Frontier Wealth Management LLC 196,750$2,184,0000.35%
View complete list of TG THERAPEUTICS INC shareholders